SciVision Biotech Inc
TWSE:1786
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.4
136.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
SciVision Biotech Inc
SciVision Biotech Inc
Current Portion of Long-Term Debt
SciVision Biotech Inc
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SciVision Biotech Inc
TWSE:1786
|
Current Portion of Long-Term Debt
NT$1.2m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Current Portion of Long-Term Debt
$801k
|
CAGR 3-Years
14%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-30%
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Current Portion of Long-Term Debt
NT$191.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pegavision Corp
TWSE:6491
|
Current Portion of Long-Term Debt
NT$41.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Current Portion of Long-Term Debt
NT$60.4m
|
CAGR 3-Years
59%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
See Also
What is SciVision Biotech Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
1.2m
TWD
Based on the financial report for Sep 30, 2024, SciVision Biotech Inc's Current Portion of Long-Term Debt amounts to 1.2m TWD.
What is SciVision Biotech Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-4%
Over the last year, the Current Portion of Long-Term Debt growth was -3%. The average annual Current Portion of Long-Term Debt growth rates for SciVision Biotech Inc have been -84% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
